Synthesis of 23,23-Difluoro-24-nor- and 24′,24′-Difluoro-24-Homovitamin D3 Analogues and Unexpected Structure-Activity Relationships
Authors:
- Fumihiro KawagoeFKFumihiro Kawagoe
- Hiroya TabuchiHTHiroya Tabuchi
- Taiyo IdeguchiTITaiyo Ideguchi
- Yuki OkamotoYOYuki Okamoto
- Souma MurataSMSouma Murata
- Tomofumi YatsuTYTomofumi Yatsu
- Syota YamadaSYSyota Yamada
- Kaori YasudaKYKaori Yasuda
- Yusuke AkagiYAYusuke Akagi
- Masashi TakanoMTMasashi Takano
- Toshie FujishimaTFToshie Fujishima
- Yoshiki MiyataYMYoshiki Miyata
Open Access
Abstract
We synthesized two vitamin D3 analogues, 3 and 4, which have a shortened or elongated fluoro-side-chain based on 24,24-difluoro-25-hydroxyvitamin D3 (5) using an efficient convergent approach and studied their preliminary biological activity. Both analogues exhibited greater resistance to CYP24A1-mediated metabolism than the natural 25-hydroxyvitamin D3 (6), although their stability was lower than that of 5. Analogue 3 showed an approximately 100-fold lower human vitamin D receptor (hVDR)-binding affinity compared with 5 and 6. Despite this marked reduction in VDR-binding affinity, it demonstrated an approximately 1.5-fold increase in VDR-ligand binding domain (LBD) transcriptional activation of the natural ligand 6. In contrast, analogue 4 displayed moderate VDR-binding affinity and VDR-LBD transactivation compared with 5 and 6. We found that compound 3 is a unique vitamin D analogue with a fluorinated and shortened side-chain, exhibiting low binding affinity for hVDR but potent transcriptional activity through VDR-LBD with its long half-life; thus, 3 may serve as a basic structural skeleton for advancing medicinal chemistry and drug discovery.Keywords
Funding Information
- Japan Society for the Promotion of Science (22K14688)
- Japan Society for the Promotion of Science (23K06029)
- Japan Society for the Promotion of Science (22H02263)
- Koyanagi Foundation
- Teikyo University
This publication has 25 references indexed in Scilit:
- Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 systemJournal of Biological Chemistry, 2021
- Introduction of fluorine atoms to vitamin D3 side-chain and synthesis of 24,24-difluoro-25-hydroxyvitamin D3The Journal of Steroid Biochemistry and Molecular Biology, 2019
- Development of a highly sensitive in vitro system to detect and discriminate between vitamin D receptor agonists and antagonists based on split-luciferase techniqueThe Journal of Steroid Biochemistry and Molecular Biology, 2018
- Recent developments for introducing a hexafluoroisopropanol unit into the Vitamin D side chainThe Journal of Steroid Biochemistry and Molecular Biology, 2018
- Vitamin D Metabolism, Mechanism of Action, and Clinical ApplicationsChemistry & Biology, 2014
- Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1α,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivityArchives of Biochemistry and Biophysics, 2007
- Metabolism of A-ring diastereomers of 1α,25-dihydroxyvitamin D3 by CYP24A1Biochemical and Biophysical Research Communications, 2004
- Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidismJournal of Bone and Mineral Metabolism, 1998
- TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors.The EMBO Journal, 1996
- Synthesis of 24,24-difluoro- and 24ξ-fluoro-25-hydroxyvitamin D3Tetrahedron Letters, 1979